The retinoblastoma gene: Its role in cell cycle and cancer

In Vivo

Volumn 10, Issue 2, 1996, Pages 223-228

  Giordano, Antonio ^a   Kaiser, H E ^b,c  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cancer; Cell cycle; Retinoblastoma gene; Tumor suppressor gene

Indexed keywords

GENE PRODUCT; TRANSCRIPTION FACTOR;

ARTICLE; CANCER GENETICS; CELL CYCLE; CELL DIFFERENTIATION; RETINOBLASTOMA; TUMOR SUPPRESSOR GENE;

EID: 0030061017     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Knudson AG: Mutation and cancer: statistical study of retinoblastoma. Procf Nat Acad Scil USA 68: 820-823, 1971.
2. Francke U: Retinoblastoma and chromosome 13. Birth Defects 12: 131-137, 1978.
3. Balaban G: Gilbertl F, Nichols W, Meadows AT and Shields J: Abnormalities of chromosome 13 in retinoblastomas from individuals with normal constitutional karyotypes. Cancer Genet Cytogenet 6: 213-221, 1982.
4. Cavenee WK, Dryja TP, Philips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, and White RL: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305: 779-784, 1983.
5. Cavenee WK, Hansen MF, Nordenskjold M, Kock E, Maumenee I, Squire J, Philips RA and Gallie B.L: Genetic origin of mutations predisposing to retinoblastoma. Science 223: 501-503, 1985.
6. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM and Dryja TP: A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643-646, 1986.
7. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY and Lee EY: Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235: 1394-1399, 1987.
8. Fung YK, Murphree AL, T'Ang A, Qian J, Hinrichs SH and Benedict WF: Structural evidence for the authenticity of the human retinoblastoma gene. Science 236: 1657-1661, 1987.
9. Huang HJ, Yee JK, Shew JY, and Chen PL: Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242: 1563-1566, 1988.
10. Bookstein R, Shew JY, Chen PL, Scully P and Lee WH: Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247: 712-715, 1990.
11. Goodrich DW, Wang NP, Qian YW, Lee EY and Lee WH: The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67: 293-302, 1991.
12. De Caprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, Marsilio E, Paucha E and Livingston DM: SV40 Large Tumor Antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54: 275- 283, 1988.
13. Dyson N, Howley P Muenger K Harlow E: The human Papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934-937, 1989.
14. Whyte P, Buckovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA and Harlow E: Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334: 124-127, 1988.
15. Chellapan SP, Hiebert S, Mudryj M, Horowitz JM and Nevins JR: The E2F transcription factor is a cellular target for the RB protein. Cell 65: 1053-1061, 1991.
16. Hiebert SW, Chellapan SP, Horowitz JM and Nevins JR: The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 6: 177-185, 1992.
17. Qian Y, Luckey C, Horton L, Esser M and Templeton DJ: Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol Cell Biol 12: 5363-5372, 1992.
18. Qin XQ, Chitteden T, Livingston DM and Kaelin WG: Identification of a growth suppressive domain within the retinoblastoma gene product. Genes Dev 6: 953-964, 1992.
19. Weinberg RA: Tumor suppressor genes. Science 254: 1138-1146, 1991.
20. Knudson AG: Retinoblastoma: clues to human oncogenesis. Science 228: 1028-1033, 1984.
21. Horowitz JM, Yandell DW, Park SH, Canning S, Whyte P, Buchkovich K, Harlow E, Weinberg RA and Dryja TP: Point mutational inactivation of the retinoblastoma antioncogene. Science 243: 937-940, 1989.
22. Kaye FJ, Kratzke RA, Gerster JL and Horowitz JM: A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc Natl Acad Sci USA 87: 6922-6926, 1990.
23. Bookstein R, Rio P, Madreperla SA, Hong F, Allred C, Grizzle WE and Le W.H: Promoter deletion and loss of retinoblastoma gene in human prostate carcinoma. Proc Natl Acad Sci USA 87: 7762-7766, 1990.
24. Horowitz JM, Par SH, Bogenmann E, Cheng JC, Yandell DW, Kaye FJ, Minna JD, Dryja TP and Weinberg RA: Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci USA 87: 2775-2790, 1990.
25. Chen PL, Scully P, Shew JY, Wang JYJ and Lee WH: Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58: 1193-1198, 1989.
26. De Caprio JA, Furukawa Y, Ajchenbaum F, Griffin JD and Livingston DM: The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc Natl Acad Sci USA 89: 1795-1798, 1992.
27. Hollingsworth RE, Hensey CE and Lee W-H: Retinoblastoma protein and the cell cycle. Curr Opin Genet Dev 3: 55-62, 1993.
28. Grana X, De Luca A, Sang N, Fu Y, Claudio P, Rosenblatt J, Morgan DO and Giordano A: PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc Natl Acad Sci USA 91: 3834-3838, 1994.
29. Dulic V, Lees E and Reed SI: Association of human cyclin E with a periodic G1-S phase protein of kinase. Science 257: 1958-1961, 1992.
30. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato JY and Livingston DM: Functional interactions of the retinoblastoma protein with human D-cyclins. Cell 73: 487-497, 1993.
31. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A and Weinberg RA: Physical interaction of the retinoblastoma protein with human Dcyclins. Cell 73: 499-511, 1993.
32. Kato J, Matsushime H, Hiebert SW, Ewen ME and Sherr CJ: Direct binding of cyclin-D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7: 331-342, 1993.
33. Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR and Roberts JM: Formation and activation of a cyclinE-cdk2 complex during the G1 phase of the human cell cycle. Science 257: 1689-1694, 1992.
34. Bandara LR and La Thangue NB: Adenovirus Ela prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature 351: 494-497, 1991.
35. Bagchi S, Weinmann R and Raychaudhuri P: The retinoblastoma protein co-purifies with E2F-I, and E1A-regulated inhibitor of the transcription factor E2F. Cell 65: 1063-1072, 1991.
36. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM and Nevins JR: The E2F transcription factor is a cellular target for the RB protein. Cell 65: 1053-1061, 1991.
37. Chitteden T, Livingston DM and Kaelin WG: The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell 65: 1071-1082, 1991.
38. Kovesdi I, Reichel R and Nevins JR: Identification of a cellular transcription factor involved in E1A trans-activation. Cell 45: 219-228, 1986.
39. Nevins JR: A link between the Rb tumor suppressor protein and viral oncoprotein. Science 258: 424-429, 1992.
40. Sala A, Nicolaides NC, Engelhard A, Bellon T, Lawe DC, Arnold A, Grana X, Giordano A and Calabretta B: Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of Cell cycle-related genes in human cells. Cancer Res 54: 1402-1406, 1994.
41. Bandara LR, Adamczewski J, Hunt T and La Thangue NB: Cyclin A and the retinoblastoma gene product complex with a common transcription factor. Nature 552: 249-251, 1991.
42. Raychaudhuri P, Bagchi S, Devoto SH, Kraus VB, Moran E and Nevins JR: Domains of the adenovirus E1A protein that are required for oncogenic activity are also required for dissociation of E2F transcription factor complex. Genes Dev 5: 1200-1211, 1991.
43. Hiebert SW, Chellapan SP, Horowitz JM and Nevins JR: The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 6: 177-185, 1992.
44. Ivey-Hoyle M, Conroy R, Huber HE, Goodhart PJ, Oliff A, Heimbrook DC: Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol Cell Biol 13: 7802-7812.
45. Beijersbergen RL, Kerkhoven RM, Zhu L, Voorhoeve FM, Bernards R: E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev 5: 2680-2690, 1994.
46. Ginberg D, Vairo G, Chittenden T, Xiao Z-X, Xu G, Wydner KL, DeCaprio JA, Lawrence JB, Livingston DM: E2F4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev 8: 2665-2679, 1994.
47. Bandara LR, Buck VM, Zamanian M, Johnston LH, La Thangue, NB: Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J 13: 4317-4324, 1993.
48. Bandara LR, Lam EW-F, Sorensen TS, Zamanian M, Girling R, La Thangue NB, DP-1: a cell cycle-regulated and phosphorylated component of transcription factor DRTF1/E2F which is functionally important for recognition by pRb and the adenovirus E4 orf 6/7 protein. EMBO J 13: 3104-3114, 1994.
49. Krek W, Ewen ME, Shirodkar S, Arany Z, Kaelin WG, Livingston DM, Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78: 161-172, 1994.
50. Mayol X, Grana X, Baldi A, Sang N, Hu Q and Giordano A: Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the Ela transforming domain. Oncogene 8: 2561-2566, 1993.
51. Sang N, Baldi A and Giordano A: The roles of tumor suppressors pRb and p53 in cell proliferation and cancer. Mol and Cell Differ 3: 1-29, 1995.
52. Zhu L, Van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston DM, Dyson N and Harlow E: Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 7: 1111-1125, 1993.
53. Claudio PP, Howard CM, Baldi A, De Luca A, Fu Y, Condorelli G, Sun Y, Colburn N, Calabretta B and Giordano A: p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res 54: 5556-5560, 1994.
54. Yeung RS, Bell DW, Testa JR, Mayol X, Baldi A, Grana X, Klingalevan K, Knudson AG and Giordano A: The retinoblastomarelated gene, RB2, maps to human chromosome 16q12 and rat chromosome 19. Oncogene 8: 3465-3468, 1993.
55. Giordano A, McCall C, Whyte P, Franza BR: Human cyclin A and the retinoblastoma protein interact with similar but distinguishable sequences in the adenovirus E1A gene product. Oncogene 6: 481-485, 1991.
56. Giordano A, Lee J, Scheppler JA, Herrmann C, Harlow E, Deuschle U, Beach D, Franza BR: Cell-Cycle Regulation of Histone H1 Kinase Activity Associated with the Adenoviral Protein E1A. Science 253: 1271-1275, 1991.
57. Schwarz, J.K., Devoto, S.H., Smith, E.J., Chellapan, S.P., Jakoi, L., and Nevins, J.R., Interactions of the p107 and Rb proteins with E2F during the cell proliferation response. EMBO J 12: 1013-1020, 1993.
58. Cobrinik D, Whyte P, Peeper DS, Jacks T and Weinberg RA: Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev 7: 2392-2404, 1993.
59. Cao L, Faha B, Dembski M, Tsai LH, Harlow E and Dyson N: Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 355: 176-179, 1992.
60. Shirodkar S, Ewen M, DeCaprio JA, Morgan J, Livingston DM and Chitteden T: The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 66: 157-166, 1992.
61. Baldi A, De Luca A, Claudio PP, Baldi F, Giordano GG, Tommasino M, Paggi M and Giordano A: The Rb2/p130 gene product is a nuclear protein whose phosphorylation is cell cycle regulated. Cell Biochem 55: 402-408, 1995.
62. Vairo G, Livingston DM and Ginsberg D: Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes & Dev 9: 869-881, 1995.
63. Sardet C, Vidal M, Cobrinik D, Geng Y, Onufryk C, Chen A and Weinberg RA: E2F4 and E2F5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci USA 92: 2403-2407, 1995.
64. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH and Bradley A: Mice deficient for RB are nonviable and show defects in neurogenesis and hematopoiesis. Nature 359: 288-294, 1992.
65. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA and Weinberg RA: Effects of an Rb mutation in the mouse. Nature 395: 295-300, 1992.
66. Clarke AR, Mandag AR, Roon MV, Lugt NM, Valk MV, Hooper ML, Berns A and Riele HT: Requirement of a functional Rb-1 gene in murine development. Nature 359: 328-330, 1992.
67. Condorelli G, Testa U, Valtieri M, De Luca A, Barberi T, Vitelli L, Montesoro E, Campisi S, Giordano A and Peschle C: Modulation of retinoblastoma gene in normal adult hematopoiesis: Peak expression and functional role in advanced erythroid differentiation. Proc Natl Acad Sci USA 92: 4808-4812, 1995.
68. Wang CY, Petryniak B, Thompson CB, Kaelin WG and Leiden JM: Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science 260: 1330-1335, 1993.
69. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V and NadalGinard B: Interaction of mitogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72: 309-324, 1993.
70. Welch PJ and Wang JY: A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75: 779-790, 1993.
71. Dunaicf JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, Begemann M, Crabtree GR and Goff SP: The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79: 119-130, 1994.